Prelude Capital Management’s US Physical Therapy USPH Stock Holding History

Prelude Capital Management’s Portfolio USPH Stock Details USPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,633	Closed	-$288K	–	1931
2022 Q2	$288K	Sell	2,633 -157	-6%	-$16.7K	0.01%	1082
2022 Q1	$277K	Buy	+2,790	New	+$266K	0.01%	1106
2017 Q4	–	Sell	-1,200	Closed	-$74K	–	1738
2017 Q3	$74K	Buy	+1,200	New	+$73.1K	0.01%	983
2016 Q2	–	Sell	-1,400	Closed	-$70K	–	1754
2016 Q1	$70K	Buy	+1,400	New	+$69.6K	0.01%	872
2015 Q4	–	Sell	-2,100	Closed	-$94K	–	1701
2015 Q3	$94K	Buy	+2,100	New	+$105K	0.01%	861
2015 Q2	–	Sell	-3,200	Closed	-$152K	–	2056
2015 Q1	$152K	Sell	3,200 -900	-22%	-$38.3K	0.02%	793
2014 Q4	$172K	Sell	4,100 -2,800	-41%	-$110K	0.03%	723
2014 Q3	$244K	Buy	6,900 +2,900	+73%	+$103K	0.03%	628
2014 Q2	$137K	Buy	4,000 +3,480	+669%	+$112K	0.02%	921
2014 Q1	$18K	Buy	+520	New	+$17.3K	﹤0.01%	1712
2013 Q4	–	Sell	-1,100	Closed	-$34K	–	1934
2013 Q3	$34K	Buy	+1,100	New	+$32.5K	0.01%	1075

Other funds holding USPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prelude Capital Management's USPH Position: Q3 2022 in Review

Prelude Capital Management sold out of US Physical Therapy (USPH) in Q3 2022, closing a stake of 2,633 shares — an estimated $288K sold.

Prelude Capital Management first reported a position in USPH in Q3 2013 and held it in 11 quarters. The position peaked at $288K in Q2 2022. 196 funds tracked by Wall St. Rank hold USPH as of Q3 2022.

Prelude Capital Management reported no remaining US Physical Therapy position as of Q3 2022 after selling out during the quarter.
Prelude Capital Management sold 2,633 US Physical Therapy shares in Q3 2022, an estimated $288K.
Prelude Capital Management first reported a position in US Physical Therapy in Q3 2013 and held it in 11 quarters.
Prelude Capital Management's US Physical Therapy position peaked at $288K in Q2 2022.
196 funds tracked by Wall St. Rank held US Physical Therapy as of Q3 2022.

Based on Prelude Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.